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Abstract Duringthelastseveralyears,livetissueimaging,in
particular using two-photon laser microscopy, has advanced
our understanding of leukocyte trafficking mechanisms.
Studies using this technique are revealing distinct molecular
requirements for leukocyte migration in different tissue
environments. Also emerging from the studies are the
ingenious infrastructures for leukocyte trafficking, which are
produced by stromal cells. This review summarizes the recent
imaging studies that provided novel mechanistic insights into
invivoleukocytemigrationessentialforimmunosurveillance.
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Introduction
Leukocyte migration is fundamental for the immune
system function, and understanding of its mechanisms
is profoundly beneficial to pathological diagnosis of
inflammatory diseases or cancer, and also to clinical
regulation of the immune system [1–4]. Although much
has been learned about the mechanisms of leukocyte
migration from experiments using isolated cells and from
static histological analysis, a new approach was needed to
understand dynamics of in vivo leukocyte migration.
Recent studies using two-photon laser microscopy
(TPLM) started to reveal the behavior of lymphocytes
and other leukocytes within various tissues [5, 6].
Molecular requirements for leukocyte migration in the
native environment can now be directly tested by this
imaging technique with high 3D resolution. This review
attempts to summarize the mechanisms of in vivo
leukocyte migration that have been revealed or proposed
by the two-photon imaging studies. The cellular and
molecular environments important for leukocyte migration
are described. Then the requirements for leukocyte surface
and intracellular molecules in their in vivo migration are
discussed. Lastly, novel mechanistic insights into in vivo
lymphocyte chemotaxis and tissue entry and egress are
discussed.
Tissue scaffolds and extracellular cues for leukocyte
migration
Cellular and non-cellular scaffolds for leukocyte migration
The first example of leukocyte migration directly
observed in the intact tissue by TPLM was lymphocyte
migration in the lymph node parenchyma [7]. Naïve T
and B cells were observed to travel in the lymph node at
about 10 and 6 μm/min, respectively. This rapid migration
of lymphocytes is most likely essential for their efficient
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revealed that migration of polyclonal B cells contributes to
antigen transport for humoral immune responses [9, 10].
Migration of naïve lymphocytes did not show gross
directionality and had characteristics of random walk,
although some cells were occasionally observed to take
similar migration paths [6, 11]. Later, it was shown that
these cells migrated on the network formed by fibroblastic
stromal cells, including fibroblastic reticular cells (FRCs)
in the T cell zone and follicular dendritic cells (FDCs) in
the B cell follicle [12]. The stromal cell network is dense
and complex, thereby providing lymphocytes with numer-
ous migration paths. In addition to migrating along the
stromal network, lymphocytes are frequently observed to
migrate through the network not in parallel directions with
any visible stromal fibers. In this case, lymphocytes may
move from one fiber to another by simultaneously
interacting with multiple fibers, and/or they may migrate
on scaffolds that are not visualized, including superfine
stromal fibers. Lymphocytes that appear at almost same
locations in the network at different time points seem to be
able to migrate in different directions. What determines
directionality for each lymphocyte at a certain location is
currently unknown.
FRC-associated T cell migration was also observed in
the periarteriolar lymphoid sheath of the spleen [13].
Similar dynamic interactions between lymphocytes and
fibroblasts most likely take place in other lymphoid tissues
like Payer’s patches or lamina propria. However, these
interactions in the mucosa-associated lymphoid tissue have
not been dynamically analyzed. A similar fibroblastic
network was observed in the brain after infection with
Toxoplasma Gondi, and was suggested to serve as the
scaffold for infiltrated effector CD8
+ T cells [14]. The
lymphoid tissues also contain many motile cells other than
Tand B cells, including subsets of dendritic cells (DCs) and
natural killer cells [15–18]. Their dynamic interactions with
FRCs have not been extensively analyzed by TPLM.
In the lymphoid tissue, most of collagen-rich extracellu-
lar matrix (ECM) fibers are thought to be ensheathed by
fibroblasts which produce collagen fibers and other ECM
components [18, 19]. However, in other non-lymphoid
tissues such as skin, collagen-rich fibers may be more
exposed to infiltrating leukocytes, thereby directly serving
as scaffolds for migration. In the delayed hypersensitivity
model in the rat skin, CD4
+ effector T cells were seen to
migrate along bundles of collagen fibers [20]. The ECM is
also suggested to serve as the scaffold for T cell migration
in the tumor environment [21]. The major migration mode
for leukocytes is thought to be amoeboid migration which
does not require the remodeling of ECMs [22]. In fact, even
within the artificial collagen matrices activated T cell
migration was independent of matrix degradation by matrix
metalloproteinases (MMPs) or other proteases [23]. None-
theless, some MMPs including MMP-9 that degrades
several types of collagen are upregulated in self-reactive T
cells infiltrated into the spinal cord in the rat experimental
autoimmune encephalitis model [24]. Thus, effector T cell
migration in the non-lymphoid tissue may also employ
matrix remodeling depending on the microenvironment.
In addition to fibroblasts and the ECM, other cell types
can also serve as the scaffold for leukocyte migration. In
the lumens of the blood vessels and lymphatic vessels,
leukocytes crawl on endothelial cells. T cells were observed
to crawl on the luminal wall of high endothelial venules
(HEVs) and other blood vessels before they transmigrate
into the lymphoid tissues and inflamed tissues [12, 24, 25].
T cells that have entered lymphatic sinuses in the lymph
node cortex crawl in the sinus lumen before they exit the
lymph node [26]. Migrating T cells in the tissue also come
into direct contact with antigen-presenting cells (APCs) to
recognize their antigens. T cell crawling on DCs has been
visualized in the lymph node [11, 27]. It is not clear,
however, whether T cells crawling on DCs are completely
detached from FRCs, because localization of DCs is also
associated with the FRC network [18]. T cells that
encountered their antigen are stably conjugated onto DCs
or other APCs, and the conjugation can last several hours
[11, 27–29]. In the early phase of the T-dependent antibody
response, helper T cells are conjugated with cognate
antigen-presenting B cells in the lymphoid tissues like
lymph nodes. The B-T conjugates are motile with B cells
migrating ahead of conjugated T cells [29–31], which
possibly allows the exchange of partners among conjugates
to generate the optimal responses. Movement of the B-T
conjugates seems to be, at least in part, associated with the
stromal cell network. Figure 1 and Video 1 show that
antigen-specific B-T conjugates are migrating on and
through the network of radiation-resistant cells in an
explants lymph node 36 h after immunization.
Scaffold-associated molecules sustaining leukocyte
migration
The scaffold must provide migrating leukocytes with
traction or anchoring, the support for the force generation.
Indeed, to analyze in vitro T cell migration on the 2D
substrate, coating with adhesion molecules like integrin
ligands is often employed. As FRCs in the lymph node
express integrin ligands like ICAM-1 and VCAM-1 [18],
which are known to play vital roles for leukocyte homing to
the tissues, these molecules have been speculated to play
essential roles in providing the support for leukocyte
migration in the lymphoid tissue. In addition, many of the
ECM components including collagen, laminin, and fibro-
nectin are integrin ligands, favoring the possibility of
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skin and tumor. However, as described in a subsequent
section, the imaging studies started to reveal that integrins
make rather limited contributions to leukocyte migration in
the 3D environment. When sufficiently dense, the FRC-DC
network or 3D collagen matrix surrounding leukocytes may
be able to provide the physical support for the migration
force without using specific adhesion molecules [32]. Yet,
the possibility is not excluded that FRCs express specific
molecules indispensable for generating traction.
Chemokines, the G-protein coupled receptor (GPCR)
ligands known to promote cell migration, are expressed by
many types of stromal cells including FRCs, FDCs, and
endothelial cells that serve as the migration scaffold [1, 18].
FRCs express CCL19 and CCL21, the ligands for CCR7
expressed on lymphocytes and DCs [1, 33]. FDCs strongly
express CXCL13, the ligand for CXCR5 expressed on B
cells and subsets of helper T cells [1]. HEVendothelial cells
express the ligands for CCR7 and CXCR5 [34, 35]. Other
chemokines involved in inflammation and tissue-selective
homing of leukocytes are also expressed by various vascular
endothelial cells [36]. CXCL12, the ligand for CXCR4, is
expressed by pericyte-like cells associated with HEVs and
possibly to a lesser extent by FRCs in the lymph node T
zone [34, 37]. Lymphatic endothelial cells also express
CCL21 [1]. Importantly, chemokines are presented on the
surface of the stromal cells. Heparan- and chondroitin-sulfate
proteoglycans present on the stromal cells form complexes
with chemokines, and other molecules like integrin ligands
may also help adsorb chemokines on the stromal cell surface
[1, 38]. Indeed, in the immunofluorescence analysis of the
lymph node section, CCL21 was observed to be concentrat-
ed in the surface area of FRCs [12, 38]. The immobilized
chemokines on the substrate are much more potent in
enhancing in vitro lymphocyte motility than chemokines in
solution [38]. The chemokine-proteoglycan complex is also
present on endothelial cells and in the ECM including the
basement membrane [39].
Leukocyte intrinsic molecular requirements in in vivo
migration
Integrins and CD44
Integrins, a family of surface glycoproteins, play the vital role
in leukocyte homing from the blood to the tissues, especially
in the step of adhesion to endothelial cells [40]. In addition,
integrins provide anchoring necessary for the force trans-
duction in mesenchymal migration of fibroblasts or tumor
cells [41, 42]. However, their roles in amoeboid migration of
leukocytes in vivo have been elusive. T cell migration in the
artificial collagen matrix was shown to be unaltered by the
treatment with an antibody cocktail that block multiple
integrins [43]. Although the collagen matrix might not be a
good model scaffold to study interstitial migration in the
lymph node, where collagen fibers are encased by FRCs, the
recent two-photon imaging studies also underscored the
limited role for integrins in leukocyte interstitial migration in
the lymph node. Integrins are heterodimers, each composed
Fig. 1 Migration of the B cell-T cell conjugate in the stromal cell
network in the lymph node. The time lapse images show dynamics
of cognate antigen-specific B cells (green) and helper T cells (red).
Relatively sessile structures in cyan are primarily radiation-resistant
stromal cells. Rapidly migrating cyan cells are presumed to be
radiation-resistant memory T cells based on flow cytometric analysis
of cells from the lymph node. Carboxyfluorescein diacetate
succinimidyl ester (CFSE)-labeled, hen egg lysozyme (HEL)-
specific B cells from Hy10 (also known as VDJ9/κ5) mice [109]
and 5-(and-6)-(((4-chloromethyl)benzoyl)amino)tetramethylrhod-
amine (CMTMR)-labeled, ovalbumin (OVA)-specific CD4 T cells
from OT-II mice were adoptively transferred to a β-actin-CFP mouse
[109] that had been lethally irradiated and reconstituted with bone
marrow cells from wild type mice. One day after transfer, the
recipient mouse was subcutaneously immunized with HEL-OVA
conjugated protein emulsified in complete Freund’s adjuvant. An
inguinal lymph node was excised 36 h after immunization and
imaged by TPLM in the perfusion chamber as previously described
[29, 109]. The excitation wavelength was 900 nm. The wavelengths
of detected emission were 467–499 nm (for CFP
+ cells), 520–
550 nm (for CFSE-labeled cells), and 565–605 nm (for CMTMR-
labeled cells). Arrowheads indicate the same B-T conjugate. Time
elapsed from the far left image is shown as minutes/seconds. The
images are presented as 60 μm z projections. The scale bars show
30 μm on the nearest x-y plane from the viewpoint. See also
supplementary Video 1.
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eight β-subunits, and 24 αβ pairs identified in mammals
[44]. LFA-1 integrin (the αL-β2 integrin heterodimer that
binds ICAMs) is known to be a major player in T cell
adhesion to endothelial cells or DCs. CD18 (β2 integrin)-
deficient T cells show slightly reduced motility compared to
wild-type T cells [38]. On the other hand, antibody blockade
of αL integrin did not reduce interstitial motility of T cells in
the lymph node [25]. These results seem to be discrepant
because CD18 is thought to pair up with only αLi n t e g r i no n
naïve T cells, and the reason for this discrepancy is not clear.
The blockade of α4 integrin slightly reduced wild-type Tcell
motility, but did not show an additive effect on motility of
CD18 knockout Tcells [38]. The combined in vivo blockade
of ICAM-1 and VCAM-1 (a ligand for α4 integrins) also
slightly reduced B cell motility in the lymph node [45]. Sixt
and colleagues extensively examined the roles for integrins
in DC migration by genetically ablating all the known
integrin heterodimers, and concluded integrins are dispens-
able for DC migration in the lymph node and skin [46].
Although some of these studies and another report suggest
that integrins play some roles in high-velocity movements of
leukocytes [47], all of these studies agree that leukocyte
interstitial migration examined so far can be largely
sustained without integrins. More studies in the future are
needed to test the involvement of integrins in other leukocyte
migration in the various tissue environments.
Another cell surface molecule that can interact with the
ECM is CD44, which is expressed in many types of
leukocytes. In T cells, CD44 is upregulated after activation
via the T cell receptor, and memory T cells maintain high
CD44 expression. The glycosylated extracellular domain of
CD44 can interact with various ECM components, includ-
ing hyaluronic acid, fibronectin, laminin, collagen, and
osteopontin, and the intracellular domain can bind to ERM
(Ezrin, Radixin, Moesin) actin-anchoring proteins [48].
Recent studies visualized dynamics of cytotoxic T lympho-
cytes (CTLs) in the tumor formed by subcutaneously
injected thymoma cells [21, 48–50]. Effector CTLs were
observed to crawl along the ECM fibers in the tumor [21,
49]. Interestingly, intratumoral migration was impaired by
CD44-deficiency in CTLs, resulting in reduced tumor-
screening capacity of these cells. However, while the
intracellular domain of CD44 that recruits ERM proteins
was necessary, the extracellular domain was not required
for CD44-dependent motility, disputing the requirement for
CD44 binding to the ECM in intratumoral CTL migration
[48].
Chemokine receptors and other GPCRs
GPCRs, particularly those coupled to Gαi/βγ heterotri-
meric G protein (Gi)-mediated signaling, are known to
promote cell migration. Recent imaging studies revealed
that Gi signaling is indeed requisite for interstitial migration
of lymphocytes. The treatment with pertussis toxin, which
inhibits Gi signaling, strongly reduced motility of both
naïve B and T cells in the lymph node [51–54]. Among the
members of the Gαi subfamily, Gαi2 was shown to be the
most important for both B and T cell migration [51, 54]. In
addition, B cell migration was significantly enhanced
without RGS (G protein Signaling)1, a member of the
Regulator of RGS family that attenuates the signaling
activity of G proteins [51].
The involvement of the chemokine receptor CCR7 in
Gi signaling-dependent T cell motility was recently
revealed by three groups using two-photon imaging of
the lymph node [52, 54, 55]. The genetic depletion of
CCR7-dependent signaling partially reduced interstitial
motility of naïve T cells. These studies used different
lymph node preparations, lymph node explants [52, 54],
and lymph nodes in the live animal [55], but their results
were remarkably consistent in quantitative terms. A
similar contribution of CCR7 was also shown by another
study using conventional epifluorescent microscopy of
unfixed lymph node slices although the absolute motility
of T cells in this study was lower than that analyzed by
TPLM [53]. CCR7-dependent T cell motility could
account for less than a half of the Gi-dependent T cell
motility, and GPCRs responsible for Gi-dependent, CCR7-
independent T cell motility are currently unknown.
Pharmacological blockade of CXCR4 did not further
reduce motility of CCR7-deficinet T cells [52, 53].
Individual inhibition of other GPCR signaling pathways
mediated by the lipids (thromboxanes, sphingosine 1-
phosphate (S1P), and lysophosphatidylcholine) or adeno-
sine has so far not resulted in reduced interstitial motility
of T cells in the lymph node [54, 56].
CXCR5 is a major chemokine receptor on B cells, and
is required for follicular localization of B cells and their
capturing of FDC-bound antigen [1, 57]. After capturing
cognate antigen and interacting with helper T cells, B cells
proliferate and form germinal centers (GCs) within the
follicle to mount long-lasting, high affinity antibody
responses. Recent two-photon imaging studies revealed
the migratory nature of GC B cells [30, 58, 59], and their
motility was found to be partially dependent on the
CXCR5 ligand, CXCL13 [30]. CXCR5 likely contributes
to naïve B cell motility on FDCs as well. Testing this,
however, may not be straightforward because CXCR5-
deficiency dislocates B cells from the FDC network. Naïve
B cells also express CCR7, which may contribute to their
motility even when they are in the B cell follicle since
CCL21 is present in the T-zone proximal region of the B
cell follicle [29, 60]. A recent imaging study showed
enhanced follicular migration of LPS-treated B cells,
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chemokine receptors [61].
A few other GPCRs were reported to function for
migration of cells with the myeloid origin in vivo. Acutely
after induction of tissue damage in the brain cortex, it was
observed by TPLM that microglial cells migrated toward
the injury site in response to adenosine triphasphate (ATP)
released from the site [62]. This ATP-driven migration was
found to be mediated by the P2Y12 purinoceptor, which is
coupled to the Gi signaling pathways [63]. More recently, it
has been reported that S1P can promote migration of
monocytoid cells containing osteoblast precursors in the
bone marrow, and that this lipid signaling contributes to
regulation of the mature osteoblast formation and bone
homeostasis [64].
Cytoskeletal molecules and small G proteins
The force generation for amoeboid migration is dependent
on the polarized actomyosin cytoskeleton. The protrusion at
the front mediated by the actin network expansion is the
major part of the force for leukocyte migration [32]. The
growth of the actin network requires branching of actin
filaments, which is mediated by the Arp2/3 complex. The
small GTPases Rac and Cdc42 activate the Arp2/3 complex
through the Wiskott-Aldrich syndrome protein family. Rac-
deficiency leads to rounding of DCs due to impaired
expansion of the actin network, and results in the inability
of DCs to migrate from the skin to the lymph node [65].
Cdc42 depletion in DCs severely blocks their migration in
the 3D environment by impairing the special coordination
of the actin network expansion [66]. Dock2, a guanine
nucleotide exchange factor (GEF) for Rac, was shown to be
essential for interstitial motility of T and B cells in the
lymph node [67], and is most likely important for in vivo
neutrophil migration as well [68, 69]. Interestingly, how-
ever, DCs may not depend on Dock2 to activate Rac for
their migration except for plasmacytoid DCs [70]. Vav
family proteins are also the GEF for Rac. Vav1/2/3-
deficient neutrophils showed the reduced migration speed
in the inflamed dermal tissue, while the directional
persistence of their migration was normal [47]. Vav proteins
in neutrophils were reported to act downstream of integrins
[47]. Consistent with this view, neutrophil migration in the
rat mesenteric tissue analyzed by transmitted light micros-
copy was reported to be impaired after blocking α2β1
integrin function [71]. On the other hand, genetic deletion
of all the known integrin heterodimers did not alter
neutrophil motility in collagen gels [46]. Effects of genetic
ablation of all the integrins on neutrophil interstitial
migration in vivo have not been reported.
Rac activation can be mediated by the phosphoinositide
3-kinase (PI3K) signaling pathway. PI3Kγ-deficient T cells
but not PI3Kγ-deficient B cells exhibit mildly impaired
directional persistence in the lymph node [67]. Basal
motility of naïve lymphocytes is also partially dependent
on Class IA PI3Ks [72]. Recently, it has been reported that
PI3K-produced phosphatidylinositol 3,4,5- trisphosphate
and phospholipase D (PLD)-produced phosphatidic acid
cooperatively recruit Dock2 to the plasma membrane at the
leading edge of chemotaxing neutrophils [68]. It will be
important to examine in vivo motility of lymphocytes and
neutrophils that lack both PI3Ks and PLD.
The importance of the actin network regulation in
leukocyte migration was further underscored by the
discovery that defects in the CORO1A gene encoding
Coronin 1A severely impair T cell trafficking and intersti-
tial motility [73, 74]. The Coronin family proteins bind F-
actin and inhibit the Arp2/3 complex. It is currently unclear
how exactly the regulation of branched actin polymeriza-
tion by Coronin 1A contributes to T cell motility. The
CORO1A knockout or mutant mice show striking defects
in thymic egress of mature thymocytes [73, 74]. Absence of
Coronin 1A caused by deletions in the human CORO1A
gene has been also linked to an atypical form of T
−B
+NK
+
severe combined immunodeficiency (SCID) in a patient
with the detectable thymus [74, 75]. Mice deficient in
Dock2 described above, mDia1, RAPL, or Mst1 described
below are also defective in thymocyte emigration, but none
of the genes encoding these molecules has been linked to
human SCID. Migration of other leukocytes like B cells,
NK cells, and neutrophils seems to be less dependent on
Coronin 1A, possibly due to redundant expression of other
Coronin family members [74–76].
Diaphanous-related formin (DRF) family proteins, which
are the effector molecules of the Rho small GTPase
subfamily, also stimulate actin polymerization. Unlike
Arp2/3, the DRF proteins produce unbranched actin
filaments. Deficiency in mDia1, a member of the DRF
family, impairs in vitro migration and the in vivo trafficking
of T cells [77]. However, interstitial motility of mDia1-
deficient T cells has not been directly examined by TPLM.
In addition to the formation of unbranched actin filaments,
bundling of actin filaments has also been suggested to be
important for T cell motility. A recent study using TLPM
reported that T cells deficient in an actin-bundling protein
L-plastin showed impaired motility in lymph nodes [78].
Another group of Rho effector molecules are the Rho
kinases, ROCK1 and ROCK2. Although in vivo trafficking
of T cells lacking ROCK1 and/or ROCK2 has not been
examined, inhibition of the Rho kinases by the selective
inhibitor, Y-27632, significantly suppresses in vitro T cell
chemotaxis [79]. The Rho kinases increase phosphorylation
of myosin light chains either by directly phosphorylating
the light chains or through the inhibition of myosin
phosphatases. This stimulates actomyosin contractility,
Semin Immunopathol (2010) 32:215–225 219which can promote amoeboid migration depending on the
microenvironment [32, 80, 81]. Alternatively, the Rho
kinases can also stabilize actin filaments by inactivating
actin depolymerizing and severing factors through the
phosphorylation of LIM kinases [82].
The signaling pathway involving the small GTPase Rap1
is also important for leukocyte migration. Although in vivo
motility of Rap1-deficient leukocytes has not been directly
assessed, interstitial motility of B and T cells in the lymph
node was found to be dependent on a Rap1 effector
molecule, RAPL (also known as an alternative spliced
form of Nore1 or Rassf5b) [45]. RAPL binds to the GTP-
bound form of Rap1, and this complex was shown to
activate the serine-threonine kinase Mst1, a member of the
mammalian Ste20-like kinase family [83]. Mst1-deficient
mice showed similar lymphocyte trafficking defects to
those observed in RAPL-deficient mice, including impaired
interstitial motility of B and T cells in the lymph node [84].
The Rap1-RAPL-Mst1 pathway has been best characterized
in its role for integrin-dependent adhesion. However, this
pathway is also involved in integrin-independent cell
polarization most likely through the regulation of the
actomyosin system [45, 83–86]. As the dependence of
lymphocyte interstitial motility on RAPL or Mst1 seems to
be larger than that on integrins, the Rap1-RAP-Mst1
pathway is likely to contribute cell migration both in
integrin-dependent and -independent manners.
In vivo chemotaxis and tissue entry/egress
of lymphocytes
Chemokine-guided lymphocyte migration in the lymph
node parenchyma
The concentration gradient of the environmental cues such
as chemokines is thought to be important for guiding
leukocyte trafficking. Besides ATP-driven chemotaxis of
brain microglia described above, a few studies using TPLM
have revealed that lymphocytes undergo directionally
biased interstitial migration in the chemokine receptor-
dependent manner. In the lymph node, B cells that
encountered their antigen in the B cell follicle upregulate
CCR7, and directionally migrate toward the T cell zone in
the CCR7-dependent manner [29, 87]. This directional
migration was observed only in the T cell zone-proximal
region of the follicle, approximately where the increasing
gradient of CCL21 toward the T zone could be detected.
After this directional migration, the antigen-engaged B cells
accumulate at the boundary between the follicle and T
zone, where they start dynamic interactions with cognate
helper T cells [29]. This B cell accumulation at the
boundary was shown to be achieved by the balanced
responsiveness to the CCR7 ligands in the T cell zone and
to CXCL13 in the B cell follicle [1, 87].
Positively selected thymoctes in the thymic cortex were
also observed to migrate directionally toward the thymic
medulla in the CCR7 dependent manner [88–90]. This
CCR7-dependent migration may be important for negative
selection of thymocytes in the medulla to prevent the
autoimmunity [91]. Unlike antigen-engaged B cells that are
accumulated at the border between the B cell follicle and T
cell zone, positively selected thymocytes migrate across the
cortico-medullary junction to enter into the medulla. The
medullary entry of positively selected thymocytes seems to
require additional Gi signaling pathways that have not been
identified [90].
The chemokine-guided migration was also shown to
promote CD4
+ T cell help for CD8
+ T cells, which involves
co-presentation of antigens to CD4
+ T cells and CD8
+ T
cells by the same DCs [92]. In the lymph node, it was
observed that polyclonal CD8
+ T cells were locally
attracted to DCs interacted with antigen-specific CD4
+ T
cells in the manner dependent on signaling through the
chemokine receptor CCR5. This mechanism enables CD8
+
T cells to efficiently scan for their antigen and CD4
+ T cell
help at the same time [92]. Another imaging study also
reported that CD8
+ T cells are recruited preferentially to the
cognate DC-CD4
+ T cell interaction sites [93]. Notably,
CCR5 signaling blockade reduced the number of memory
CD8
+ T cells generated after immunization but not primary
expansion of CD8
+ T cells [92, 94]. Most of polyclonal
CD8
+ T cells have to migrate away from sites of the
antigen-specific DC-CD4
+ T cell interaction after they have
scanned for their antigen at the sites. An interesting future
question is whether desensitization of CCR5 is involved in
this migration of CD8
+ T cells that is inevitably against the
concentration gradient of the CCR5 ligands.
Novel mechanistic insights into tissue entry and egress
For lymphocyte chemotaxis described above, the gradients
of chemokine concentration are most likely formed along
fibroblastic stromal cells. Concentration gradients of guid-
ance cues can be also formed between the tissue parenchy-
ma and the lumen of blood or lymphatic vessels. A recent
imaging study showed that T cells in the lymph node
parenchyma extend cell processes into the cortical sinus, a
lymphatic structure that is possibly a primary exit site of the
lymph node, before they decide to move in or leave the
sinus [26]. S1P1 (an S1P receptor)-deficient T cells that are
incapable of egressing from the lymph node also extend the
processes into the sinus, but fail to migrate into the sinus
lumen. These results suggest that T cell sensing of luminal
S1P, which is likely to be much more abundant than S1P in
the parenchyma, may drive transmigration [26, 95]. It is not
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common entry sites, although a preceding report showed
that T cells cross the boundary of a medullary sinus-like
structure at certain locations [96]. An independent study
reported that B cells also entered into the cortical sinus, and
that the entry step was inhibited by administration of an
immunosuppressant FTY720, which blocks lymphocyte
egress from the lymph node [97]. Upon administration,
FTY720 is phosphorylated in vivo. Phosphorylated FTY-
720 is a potent agonist for S1P1, but can also act as a
functional antagonist by desensitizing S1P1 signaling [1].
As B cell egress from the lymph node is also impaired by B
cell-intrinsic S1P1 deficiency [98], it is strongly suggested
that B cell transmigration into the cortical sinus is also
mediated by S1P1.
Recently, DCs were shown to enter initial lymphatic
vessels in the skin through preexisting discontinuities in the
basement membrane surrounding lymphatic endothelial
cells. After migrating through these preformed pores in
the basement membrane, DCs were observed to transmi-
grate into the vessel through lymphatic endothelial junc-
tions that can be ‘flapped’ for entering of DCs [99]. This
study visualized DC migration in ex vivo ear sheets with
the dermal surface exposed using a spinning disk confocal
microscope. DCs added onto the dermal surface migrated
into the tissue and accumulated into the lymphatics with
striking efficiency in a few hours [46, 99]. This accumu-
lation was shown to be CCR7-dependent, suggesting that
DCs are attracted to CCR7 ligands expressed by lymphatic
endothelial cells [1, 99, 100].
It is not clear whether leukocyte extravasation from the
blood vessels involves concentration gradients of guidance
cues across the endothelium. Chemokines immobilized on
the apical surface of endothelial cells, together with integrin
ligands and application of a shear flow, suffice to promote
in vitro T cell transendothelial migration [101]. Apical
chemokines and shear stress promote T cells to form
numerous dots of high affinity integrins and filopodia that
nucleate from the high affinity integrin dots. These
filopodia were observed to invade the endothelial cell
surface. Rapid turnover of these structures was proposed to
allow shear resistant, lateral crawling of T cells on
endothelial cells, and may also be required for trans-
endothelial migration [102]. Turnover of these structures
most likely requires regulation of integrin affinity, as a
recent in vivo imaging of HEVs in the lymph node by
TPLM showed that genetically engineered T cells that are
unable to down-regulate LFA-1 affinity were slower than
wild type cells in both lateral crawling and transendothelial
migration [25]. After transendothelial migration, lympho-
cytes may use discontinuities in the basement membrane
surrounding the vessel to leave into the tissue as reported
for DCs entering into lymphatics [99]. T cells extravasating
from lymph node HEVs were observed to take common
paths to leave HEVs into the parenchyma [8, 12].
B cell intravasation into the bone marrow sinusoid has
also been visualized by TPLM. Intravital imaging of
Rag1 recombinase-expressing B cells in the bone marrow
(pro-, pre-, and immature B cells) detected that some of
these B cells entered into the bone marrow sinusoids
[103]. Flow cytometric analysis of in vivo labeled
sinusoidal B cells provided evidence that Rag1-
expressing B cells in the sinusoids are immature B cells.
After entering into the sinusoids immature B cells were
observed to be retained in the sinusoids in a manner
dependent on CB2 (a cannabinoid receptor coupled to Gi
signaling) and α4i n t e g r i nb e f o r et h e ya r ed e c i d e dt ol e a v e
the sinusoids into the blood flow. The retention of
immature B cells in the sinusoid may contribute to shape
the B cell repertoire as CB2-deficiency resulted in reduced
lamda light chain-positive B cells in the periphery [103].
The same study also showed that B cell CXCR4, which
had been known to provide the retention signal in the bone
marrow, serves to retain B cells in the bone marrow
parenchyma but not in the sinusoid. Thus CXCR4 inhibits
parenchyma-to-sinusoid transmigration of developing and
mature B cells that should not leave the bone marrow
[103]. The signals responsible for selective transmigration
of immature B cells into the sinusoids have not been
identified. Other studies showed that adoptively trans-
ferred mature B cells could home to the bone marrow
parenchyma [104, 105], and survival of these B cells
depends on a cytokine called MIF (also known as GIF)
produced by bone marrow-resident DCs [104]. It will be
intriguing to test the involvement of these DCs in the
selection of developing B cells in the bone marrow.
Conclusions and perspectives
The studies described above illustrated that live imaging of
intact tissues, in particular by TPLM, is a powerful method
to investigate the cell biological and anatomical mecha-
nisms of in vivo leukocyte migration. These studies started
to highlight that leukocytes adaptively employ various
modes of migration using distinct sets of molecules to
regulate actomyosin-dependent force generation and adhe-
sion depending on the nature of the microenvironments.
They also revealed the ingenious infrastructures essential
for leukocyte migration, which are produced by stromal
cells. Importantly, as seen in the B cell-dependent devel-
opment of the FDC network, leukocytes are also involved
in the construction of the migration scaffold for themselves
[106]. However, our knowledge is still limited about
molecular requirements and mechanisms for individual
modes of in vivo leukocyte migration. Future studies will
Semin Immunopathol (2010) 32:215–225 221need not only to examine the involvement of many
molecules with the issue of functional redundancy in mind,
but also to tackle the improvement of visualization ability for
subcellular events as well as more precise microstructures in
live tissues. Efforts should be also made to clarify the
physiological significance of lymphocyte interstitial motility.
It has been suggested that even a partial defect in interstitial
motility may lead to a significant impairment in tumor cell
surveillance by effector CTLs [48]. Future studies are
expected to examine the impact of reduced lymphocyte
motility on other forms of immunosurveillance, including
surveillance by developing lymphocytes for self-antigen in
the thymic medulla or in the bone marrow [103, 107].
Another important challenge is the development of the
imaging system to study the mouse model for human
immunodeficiency caused by leukocyte trafficking defects.
For example, in order to fully understand pathological
mechanisms underlying SCID linked to Coronin 1A defe-
ciency [75], it will be essential to develop the technique to
visualize thymocytes emigration from the thymus in the
living animal. Live imaging studies have also started to
dissect effects of host-pathogen interactions on leukocyte
trafficking. For example, a study using TPLM showed that
neutrophil extravasation to the site of Streptococcus pyo-
genes infection was decelerated by Streptolysin S toxin of
the bacteria [108], highlighting the importance of imaging
studies using genetically altered pathogens to understand
mechanisms of leukocyte trafficking during the infection.
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